Found: 6
Select item for more details and to access through your institution.
Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1565, doi. 10.3390/ph16111565
- By:
- Publication type:
- Article
Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 155, doi. 10.3390/ph15020155
- By:
- Publication type:
- Article
Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, v. 12, p. 1, doi. 10.3389/fcimb.2022.1056007
- By:
- Publication type:
- Article
EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin.
- Published in:
- mLife, 2024, v. 3, n. 3, p. 459, doi. 10.1002/mlf2.12139
- By:
- Publication type:
- Article
Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2023.1304857
- By:
- Publication type:
- Article
Assessment of the Efficacy of the Antihistamine Drug Rupatadine Used Alone or in Combination against Mycobacteria.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 8, p. 1049, doi. 10.3390/pharmaceutics16081049
- By:
- Publication type:
- Article